I want to share with all my SDNCT colleagues an experience that has given us extraordinary results, later we will inform you in more detail about this trial or experience that aims to give an answer to patients with Covid-19 in such a delicate situation in this terrible and underrated situation. pandemic.
Following Australians in vitro study of Ivermectin on Covid-19, we began a clinical trial treating a significant number of patients with clinical signs and symptoms compatible with covid-19 , plus imaging studies, such as simple chest radiography, and single-phase computed tomography.
We divided the patients for dose purposes into two groups: those who were <80 kg in weight and those who were 80 kg in weight, we gave the first Ivermectin 6 mg 2 tablets, the second Ivermectin 6 mg, 3 tablets, to make the administration of the medications based on the kg of weight more practical, regardless of whether they were in classification or phase 2 or classification or phase 3
We all administered a single dose per day, repeating doses at 24 hrs, without exceeding 36 mg. Most of us did a control tomography after 72 hours.
In classification 2 there was a dramatic improvement, many of them improved after the first hours of administering the medications, some of them ceased to be symptomatic (in this group there are four doctors under treatment and two in the second group or classification 3) .
The CT scans of all underwent important changes, with progress towards improvement in the same way as those hospitalized in phase 3, in whom arterial gases also improved as well as the severity markers, as did the Torax tac.
We want to highlight that this trial - treatment was performed without being able to carry out Covid - 19 tests prior to the administration of drugs due to the low availability of the tests in national laboratories, it really constitutes an odyssey to get a test in the public sector and in the same way in the private ones due to the great demand for services; long before this trial and due to the large number of patients we have seen the need to provide clinical and imaging treatments before having a Covid-19 test detected.
It is a challenge to organize this experience to take laboratory samples before starting treatment and after having treated the patient at the relevant or defined time; We announce that we are in the process of verifying these results.
I hope we act promptly, it depends on this that thousands of Dominicans can save their lives.
[-] TrumpLyftAlles | 4 points | May 17 2020 01:24:44
I want to share with all my SDNCT colleagues an experience that has given us extraordinary results, later we will inform you in more detail about this trial or experience that aims to give an answer to patients with Covid-19 in such a delicate situation in this terrible and underrated situation. pandemic.
Following Australians in vitro study of Ivermectin on Covid-19, we began a clinical trial treating a significant number of patients with clinical signs and symptoms compatible with covid-19 , plus imaging studies, such as simple chest radiography, and single-phase computed tomography.
We divided the patients for dose purposes into two groups: those who were <80 kg in weight and those who were 80 kg in weight, we gave the first Ivermectin 6 mg 2 tablets, the second Ivermectin 6 mg, 3 tablets, to make the administration of the medications based on the kg of weight more practical, regardless of whether they were in classification or phase 2 or classification or phase 3
We all administered a single dose per day, repeating doses at 24 hrs, without exceeding 36 mg. Most of us did a control tomography after 72 hours.
In classification 2 there was a dramatic improvement, many of them improved after the first hours of administering the medications, some of them ceased to be symptomatic (in this group there are four doctors under treatment and two in the second group or classification 3) .
The CT scans of all underwent important changes, with progress towards improvement in the same way as those hospitalized in phase 3, in whom arterial gases also improved as well as the severity markers, as did the Torax tac.
We want to highlight that this trial - treatment was performed without being able to carry out Covid - 19 tests prior to the administration of drugs due to the low availability of the tests in national laboratories, it really constitutes an odyssey to get a test in the public sector and in the same way in the private ones due to the great demand for services; long before this trial and due to the large number of patients we have seen the need to provide clinical and imaging treatments before having a Covid-19 test detected.
It is a challenge to organize this experience to take laboratory samples before starting treatment and after having treated the patient at the relevant or defined time; We announce that we are in the process of verifying these results.
I hope we act promptly, it depends on this that thousands of Dominicans can save their lives.
permalink